Active Comparator clinical trials

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

This study looks at a new treatment called rapcabtagene autoleucel for severe forms of a condition called ANCA-Associated Vasculitis (AAV), specifically GPA and MPA. It aims to see how well it works and if it's safe compared to current treatments.